Abstract:Abstract Single-cell ribonucleic acid sequencing (scRNA-seq) has emerged as a transformative technology in neurological and neurosurgical research, revolutionising our comprehension of complex neurological disorders. In brain tumours, scRNA-seq has provided valuable insights into cancer heterogeneity, the tumour microenvironment, treatment resistance, and invasion patterns. It has also elucidated the brain tri-lineage cancer hierarchy and addressed limitations of current models. Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis have been molecularly subtyped, dysregulated pathways have been identified, and potential therapeutic targets have been revealed using scRNA-seq. In epilepsy, scRNA-seq has explored the cellular and molecular heterogeneity underlying the condition, uncovering unique glial subpopulations and dysregulation of the immune system. ScRNA-seq has characterised distinct cellular constituents and responses to spinal cord injury in spinal cord diseases, as well as provided molecular signatures of various cell types and identified interactions involved in vascular remodelling. Furthermore, scRNA-seq has shed light on the molecular complexities of cerebrovascular diseases, such as stroke, providing insights into specific genes, cell-specific expression patterns, and potential therapeutic interventions. This review highlights the potential of scRNA-seq in guiding precision medicine approaches, identifying clinical biomarkers, and facilitating therapeutic discovery. However, challenges related to data analysis, standardisation, sample acquisition, scalability, and cost-effectiveness need to be addressed. Despite these challenges, scRNA-seq has the potential to transform clinical practice in neurological and neurosurgical research by providing personalised insights and improving patient outcomes.

Single-cell RNA sequencing in orthopedic research

Advancing skeletal health and disease research with single-cell RNA sequencing

Single-cell RNA sequencing in osteoarthritis

Single-cell RNA Sequencing in the Context of Neuropathic Pain: Progress, Challenges, and Prospects.

Single-cell RNA-seq analysis reveals the progression of human osteoarthritis.

Advances in single‐cell sequencing and its application to musculoskeletal system research

Single-cell RNA-sequencing Analysis Reveals the Molecular Mechanism of Subchondral Bone Cell Heterogeneity in the Development of Osteoarthritis

Single Cell Transcriptomics in Human Osteoarthritis Synovium and in Silico Deconvoluted Bulk RNA Sequencing

Single-Cell Profiles of Age-Related Osteoarthritis Uncover Underlying Heterogeneity Associated With Disease Progression

Single-cell Sequencing: New Insights for Intervertebral Disc Degeneration

New Insights From Single-Cell Sequencing Data: Synovial Fibroblasts and Synovial Macrophages in Rheumatoid Arthritis

Advancing single cell technology: iSCseq drives living subcellular transcriptomic profiling in osteoimmune diversity

The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery

Combining bulk and single-cell RNA-sequencing data to reveal gene expression pattern of chondrocytes in the osteoarthritic knee

Lncrnas: Function and Mechanism in Cartilage Development, Degeneration, and Regeneration

Single-Cell RNA-Sequencing Reveals the Skeletal Cellular Dynamics in Bone Repair and Osteoporosis

Single-cell RNA sequencing analysis dissected the osteo-immunology microenvironment and revealed key regulators in osteoporosis

Single-cell RNA Sequencing of Human Femoral Head in Vivo.

Characterization of the single cell landscape in normal and osteoarthritic equine joints

Advances in single-cell sequencing: insights from organ transplantation

Single-cell RNA sequencing reveals in vivo osteoimmunology interactions between the immune and skeletal systems